Evidence map›Paper›PMID 29192684›Full record

ArticleEye (London, England)2017

Early deep anterior lamellar keratoplasty for fungal keratitis poorly responsive to medical treatment.

F Sabatino, E Sarnicola, C Sarnicola, G M Tosi, P Perri, V Sarnicola, Medscape

Open access · bronzeAbstract read
In one paragraph

Article in Eye (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Therapeutic Keratoplasty forJournal of clinical medicine · 2024
    Article
  6. Article
  7. Fungal Keratitis: Diagnosis, Management, and Recent Advances.Clinical ophthalmology (Auckland, N.Z.) · 2024
    Review
  8. Article
  9. Article
  10. Management of Filamentous Fungal Keratitis: A Pragmatic Approach.Journal of fungi (Basel, Switzerland) · 2022
    Review
  11. Current Perspectives on Corneal Transplantation.Clinical ophthalmology (Auckland, N.Z.) · 2022
    Review
  12. Recent Perspectives in the Management of Fungal Keratitis.Journal of fungi (Basel, Switzerland) · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

F SabatinoMoorfields Eye Hospital NHS Foundation Trust, London, UK.
E SarnicolaDepartment of Medicine, Surgery, and Neuroscience, University of Siena, Siena, Italy.
C SarnicolaDepartment of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy.
G M TosiDepartment of Medicine, Surgery, and Neuroscience, University of Siena, Siena, Italy.
P PerriDepartment of Biomedical and Specialty Surgical Sciences, University of Ferrara, Ferrara, Italy.
V SarnicolaAmbulatorio di Chirurgia Oculare 'Santa Lucia', Grosseto, Italy.
Medscape
University of Siena · ITMoorfields Eye Hospital NHS Foundation Trust · GBUniversity of Chicago · USUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PurposeTo investigate the efficacy of early therapeutic deep anterior lamellar keratoplasty (DALK) in eradicating fungal keratitis that is poorly responsive to medical treatment.Patients and methodsTwenty-three eyes (23 patients) underwent early therapeutic DALK within 15 to 50 days from the onset of symptoms. The adopted eligibility criteria for early DALK included the following: active fungal keratitis affecting the optical zone with ulcer confined in the 6.00 mm central cornea; deeper than 150 μm but not exceeding 300 μm; and poorly responsive to medical treatment.ResultsThe big bubble technique was accomplished in 74% (17) of eyes, whereas manual dissection was performed in the remaining 26% (6) of eyes. Histopathological examination did not show any sign of fungal colonization in the peripheral and deep stromal lamellae in any case. All grafts were transparent postoperatively, and no recurrence of infection occurred. Median best spectacle corrected visual acuity significantly improved from 2.0 (1.0 interquartile range) logMAR to 0.1 (0.1 interquartile range) logMAR (P<0.01). The mean follow-up was 32±10 months. Neither episode of rejection nor graft failure was noted during the follow-up period.ConclusionEarly DALK could represent a safe therapeutic approach to eradicate fungal keratitis that affects the optical zone and is poorly responsive to medical treatment.

Indexed as

Graft SurvivalVisual AcuityAdultAgedAntifungal AgentsCorneaEye Infections, FungalFemaleFollow-Up StudiesFungiHumansKeratitisKeratoplasty, PenetratingMaleMicroscopy, ConfocalMiddle AgedAntifungal Agents

Identifiers

PMID29192684
PMCPMC5733298
OpenAlexW2773392599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.